Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]
Sci RepPriyadharshini A +4 more
europepmc +1 more source
Metamizole induces voriconazole metabolism and results in subtherapeutic voriconazole concentrations. [PDF]
Br J Clin PharmacolBaan SD +3 more
europepmc +1 more source
Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants. [PDF]
Clin Transl SciKim JD +4 more
europepmc +1 more source
Comprehensive Molecular Evaluation of Transcription Factor 7-like 2, Long Noncoding RNA (ANRIL), and CYP2C19*17 Gene Variants and Their Association with Predisposition and Progression in Stroke Patients. [PDF]
Cell Mol NeurobiolHamadi A +10 more
europepmc +1 more source
Pharmacogenomic Calling From Whole-Exome Sequencing in the Taiwanese Population-A Real-World Experience. [PDF]
Mol Genet Genomic MedLin HH +9 more
europepmc +1 more source
GenoStaR: An R Package for Genotype to Star Allele Conversion for Major Cytochrome P450 Family of Genes. [PDF]
Clin Pharmacol TherCoulter AJ +4 more
europepmc +1 more source
The role of cytochrome P450 genetic variants in pesticide metabolism and the risk of child neurodevelopment: a systematic review. [PDF]
Front PediatrChilipweli PM +4 more
europepmc +1 more source
Optimized <i>Ginkgo biloba</i> extract EGb 761<sup>®</sup>: boosted therapeutic benefits with minimized CYP enzyme interference. [PDF]
J Pharm Pharm SciKwon S, Jeong S, Lee S.
europepmc +1 more source
Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapy [PDF]
, 2015 Bűdi, Tamás +5 more
core +1 more source
CYP2C19 Loss-of-Function Is an Independent Risk Factor of Coronary Artery Disease in Patients With Hypertension. [PDF]
J Clin Lab AnalWei G +10 more
europepmc +1 more source